Search results for: Maria Lowe
Filter search results
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Not So Fast…
28 March 2019
…Off-patent pharmaceutical products Transparency of the procurement process significantly lowers the cost to purchasers of off-patent medicines by attracting more suppliers to bid. Price transparency for off-patent products could improve…
Maynard Matters: A New Publication Covering Alan Maynard’s Contribution to Global Health Economics
13 January 2017
Maynard Matters is a new publication edited by Richard Cookson, Maria Goddard and Trevor Sheldon, published by University of York. The publication covers Alan’s contribution to global Health Economics, his…
Chronic Diseases and the Stock of Health: Quantification Using EQ-5D-5L
15 October 2019
…time. In a new study published in Health Economics, Maria Errea and colleagues assess the health-related quality of life of a population using the EQ-5D-5L instrument to, first, estimate the…
Cheap and Dirty: The Effect of Contracting Out Cleaning on Efficiency and Effectiveness
6 March 2019
Research just published in Public Administration Review, co-authored by OHE’s Professor Graham Cookson, demonstrates that contracting out auxiliary public services may lower the quality of the core service as well…
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot
29 March 2019
Transparency as a principle of good governance is not the same as transparency for improving access by lowering prices. In fact, the former often carries an opportunity cost on the…
Critique of Research Proposing to Lower NICE’s Cost-per-QALY Threshold to £12,936
2 December 2013
This paper counters recent research that recommended NICE lower its threshold from the current official £20,000-£30,000. Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost…
Why do Immigrants Report Lower Life Satisfaction?
20 July 2017
…with your life as a whole?” Respondents answer this question on a scale between and 10, with being the lowest and 10 the highest level of life satisfaction. It is…
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison
1 June 2000
…are lower in countries with strict price regulation than in countries with less restrictive regulation (the UK) or no regulation (the US). For example, the BEUC (1989b) concluded that prices…
Differential Pricing – A Win-Win Solution?
2 March 2011
…all pay the same prices, but pay according to ability to pay. This allows companies to sell at lower prices in lower income markets. The result is to allow patients…